Navigation Links
VSL#3®, Clinically-Studied Probiotic Kept Refrigerated Behind the Pharmacy Counter, Now Showing at Shelf with a Card, a First in the Probiotic Category

Gaithersburg, MD (PRWEB) August 07, 2014

Consumers have gotten used to seeing shelf cards in place of full product packages in certain categories of products, such as cold and flu, when either price or ingredients are deemed an issue for the store. Now, in an effort to offer consumers a different type of probiotic, one that is up to 10 times more potent than the average probiotic Sigma-Tau Pharmaceuticals, distributor of VSL#3® (, is introducing shelf cards for its VSL#3 line of live bacterial probiotics. The new cards will position VSL#3, a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in adults, in the probiotic aisle, where many consumers go first when looking for an over-the-counter product.

Unlike most other commercially-available probiotics, VSL#3 is a potent proprietary formulation of eight strains of live lactic acid bacteria. Because it needs refrigeration, Sigma-Tau has, up until recently, relied mainly on physicians who recommend it and send patients to the pharmacy to find it. “Oftentimes consumers who come looking for VSL#3 are unaware the product must be kept refrigerated and is behind the pharmacy counter. They first go to the probiotic shelf where they are confronted with numerous brands of probiotics, and they are confused by all the different options and can’t find VSL#3,” explains Mary Ocnean, group product director, Sigma-Tau Pharmaceuticals, Inc. “The introduction of pharmacy cards for VSL#3 will help overcome this hurdle, and alleviate any disconnect between physicians recommending VSL#3 and the patients getting lost at the shelf when they don’t see the product.”

Ocnean continues, “Creating a positive experience for the consumer at the pharmacy shelf is one of our top priorities. The introduction of the VSL#3 shelf card will help retailers provide consumers an opportunity to purchase what they intended to purchase, and also help create awareness of a product some consumers didn’t know about.” Select pharmacies nationwide have already begun to roll out the VSL#3 branded shelf cards and will continue through 2014.

Another effort to grow awareness of VSL#3 amongst consumers is the brand’s new Facebook page to be launched in 2014. According to Ocnean, “The new Facebook page will offer consumers an opportunity to connect with others interested in probiotics and IBS or ulcerative colitis, to get dietary and lifestyle tips from healthcare experts and receive special offers and promotions. It’s a great way for us to share with consumers what is going on with the brand.”

About VSL#3:
All forms of VSL#3® are medical foods and must be used under medical supervision. VSL#3 is manufactured by Sigma-Tau Pharmaceuticals, Inc. and all forms are available behind the pharmacy counter at independent pharmacies, drug stores and mass market retailers nationwide and at There are four formulations of VSL#3 products:
VSL#3 Double Strength - the most potent at 900 billion bacteria per packet, is available by prescription
VSL#3 Regular powder packets containing 450 billion bacteria (SRP: $87.72),
VSL#3 JUNIOR containing 225 billion bacteria (SRP: $54.78) and
VSL#3 capsules containing 112.5 billion bacteria (SRP: $53.00). Each proprietary formulation requires refrigeration to preserve its potency of live bacteria. Consumers can visit for more information or to purchase the product online.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
2. New VSL#3® JUNIOR probiotic for children now available
3. Gene-Tweaked Tomatoes, Probiotics Aim to Lower Your Cholesterol
4. Probiotic Action Issues a Response to an Article on Medical News Today About Synthetic Skin Research
5. Probiotic Action Releases a Statement in Regards to a Recent Miami Herald Article on Minimizing Scars
6. Probiotic Action Responds an Article on ‘Skin Care Coaches’
7. Probiotic Action Responds to an Article Discussing the Health Benefits of Probiotics
8. Probiotic Action Responds to an Article Which Reports Alcohol Intake in Relation to Skin Health
9. Probiotic Action Spokesperson Reacts to New Treatments Being Developed for Teen Acne
10. MXI Corp; Xocai Healthy Chocolate Introduces, XoBiotic Squares, A Dark Chocolate With Probiotics, Designed To Maintain A Healthy Intestinal Balance
11. Probiotic Action Responds to Article Answering Common Questions About Acne
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: